Thrombotic thrombocytopenic purpura (Moschowitz's syndrome): Current physiopathologic and new therapeutical view;Le purpura thrombotique thrombocytopenique idiopathique ou syndrome de Moschowitz: Actualites physiopathologiques et perspectives therapeutiques

Revue de Medecine Interne

Volumn 21, Issue 9, 2000, Pages 777-784

  Retornaz, F ^a   Durand, J M ^a   Poullin, P ^b   Lefevre P ^b   Soubeyrand, J ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Plasma exchange; Thrombotic microangiopathy; Thrombotic thrombocytopenic purpura; Von Willebrand's factor

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; DIPYRIDAMOLE; ENZYME; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; PREDNISONE; PROSTACYCLIN; PROTEINASE; VINCRISTINE; VON WILLEBRAND FACTOR; ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN; IMMUNOGLOBULIN G; METALLOPROTEINASE;

AUTOIMMUNE DISEASE; BACTERIAL INFECTION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; IMMUNOSUPPRESSIVE TREATMENT; PATHOPHYSIOLOGY; PLASMAPHERESIS; PROGNOSIS; REVIEW; THROMBOTIC THROMBOCYTOPENIC PURPURA; ACUTE DISEASE; BLOOD; CHRONIC DISEASE; HUMAN; IMMUNOLOGY; TREATMENT OUTCOME;

ACUTE DISEASE; ADAM PROTEINS; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; METALLOENDOPEPTIDASES; PLASMA EXCHANGE; PROGNOSIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; TREATMENT OUTCOME;

EID: 0033835620     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(00)00223-X     Document Type: Short Survey

References (66)

1. Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature
2. Thrombotic thrombocytopenic purpura: Analysis of 48 unselected cases
3. Thrombotic thrombocytopenic purpura: A thirty-year review
4. Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature
5. Improved survival in thrombotic thrombocytopenic purpura hemolytic uremic syndrome: Clinical experience in 108 patients
6. Plasmapharesis in the treatment of thrombotic thrombocytopenic purpura
7. Thrombotic thrombocytopenic purpura: The Israeli experience
8. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura
9. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome
10. Antibodies to Von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura
11. An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries: An undescribed disease
12. An acute febrile anemia and thrombocytopenic purpura with diffuse platelet thrombosis of capillaries and arterioles
13. Thrombotic thrombocytopenic purpura. Hemorrhagic diathesis with generalized platelet thromboses
14. Thrombotic microangiopathic haemolytic anaemia (thrombotic microangiopathy)
15. Clinopathologic features of thrombotic thrombocytopenic purpura
16. Early manifestation of thrombotic thrombocytopenic purpura
17. Microangiopathic hemolytic anemia: The possible role of vascular lesions in pathogenesis
18. Unusually large plasma factor VIII: Von Willebrand factor multimers in chronic relapsing thrombotic trombocytopenic purpura
19. Von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome
20. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion
21. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments producted by in vivo proteolysis
22. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura
23. Thrombotic thrombocytopenic purpura: A review
24. Thrombotic thrombocytopenic purpura like syndrome in the absence of schistocytes
25. Thrombotic thrombocytopenic purpura. The initial neurologic manifestation
26. Neurologic manifestations of thrombotic thrombocytopenic purpura
27. Thrombotic thrombocytopenic purpura associated with pancreatic islet-cell necrosis
28. Thrombotic thrombocytopenic purpura as a cause of pancreatitis
29. Thrombotic thrombocytopenic purpura as a cause of massive gastrointestinal hemorrhage, report of a case
30. The changing course of thrombotic thrombocytopenic purpura and modern therapy
31. Ocular involvement in acute thrombotic thrombocytopenic purpura
32. Early plasmapheresis in patients with thrombotic thrombocytopenic purpura
33. Porpora thrombothica thrombocitopenica (sindrome di Moschowitz)
34. Thrombotic thrombocytopenic purpura: Review of the subject with a report of three cases in children
35. Exchange transfusions in the treatment of thrombotic thrombocytopenic purpura
36. Traitement du purpura thrombotique thrombopenique
37. High incidence of relapses in thrombotic thrombocytopenic purpura. Clinical study of 38 patients
38. Thrombotic thrombocytopenic purpura
39. Subacute (acute, persistent) thrombotic microangiopathy
40. Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura
41. Refractory thrombotic thrombocytopenic purpura: Sucessful treatment by plasmapheresis with cryosupernatant
42. Treatment of thrombotic thrombocytopenic purpura with cryosupernatant
43. Cryoprecipitate poor plasma fraction (cryosupernatant) in the treatment of thrombotic thrombocytopenic purpura at onset. A report of four cases
44. Successful treatment of thrombotic thrombocytopenic purpura with high-dose corticosteroid
45. Corticosteroids in the treatment of thrombotic thrombocytopenic purpura
46. Thrombotic thrombocytopenic purpura and related disorders
47. Vinscrine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma-exchange
48. Vincristine for thrombotic thrombocytopenic purpura
49. Treatment of thrombotic thrombocytopenic purpura with vincristine
50. Use of Vincristine in refractory thrombotic thrombocytopenic purpura
51. Rapid improvement of thrombotic thrombocytopenic purpura with vincristine and plasmapheresis
52. Difficultes therapeutiques dans la prise en charge du purpura thrombotique thrombopenique: A propos d'une serie de dix cas
53. Long lasting remission after high dose intravenous immunoglobulines in a case of relapsing thrombotic thrombopenic purpura
54. Intravenous gamma globulin in refractory thrombotic thombocytopenic purpura
55. Should intravenous immunoglobulin G be first-line treatment for acute thrombotic thromcytopenic purpura? Case report and review of the literature
56. Treatment of thrombotic thrombocytopenic purpura with high dose immunoglobulins. Results in 17 patients
57. Deleterious effect of intravenous immunoglobulin in a patient with thrombotic thrombocytopenic purpura
58. Ineffectiveness of high dose intraveinous gammaglobulin infusion in thrombotic thrombocytopenic purpura
59. Inefficacy of intravenous immunoglobulin in patients with low risk thrombotic thrombocytopenic purpura/hemolytic uremic syndrome
60. Thrombotic thrombocytopenic purpura related to ticlopidine
61. Thrombotic thrombocytopenic purpura associated with ticlodipine: A review of 60 cases
62. Splenectomy done during hematologic remission to prevent relapse in patients with thrombotic thrombocytopenic purpura
63. Deleterious effects of platelet transfusions and recovery thrombocytosis in patients with thrombotic microangiopathy
64. Hazard of platelets transfusion in thrombotic thrombocytopenic purpura
65. More about thrombotic thrombocytopenic purpura
66. Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura